OR WAIT null SECS
Brian Huber is vice-president of Therapeutic Areas, Drug Development, and Consulting at ICON.
Guljit Chaudhuri is managing director, BioInnovat, New Delhi, India
Dawn E. Sailer is associate quality advisor with Eli Lilly and Company, Indianapolis, IND.
Marco Adami
Karen Waetjen is director, GCP/GLP Compliance, Amgen.
Joshua Arias, joshua.arias@milliporesigma.com, is technical leader, BioReliance End to End Solutions, MilliporeSigma.
Flora J. Keumurian, florak@mit.edu, is program and operations manager at MIT Center for Biomedical Innovation.
Weihong Wang is technology development director at Eurofins BioPharma Product Testing.
Roland Mainil is director, Technical Development Lead at GSK, Rixensart, Belgium.